Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE

被引:83
作者
Olivier, Chamion N. [1 ]
Blake, Ruth K. [1 ]
Steed, Lisa L. [1 ]
Salgado, Cassandra D. [1 ]
机构
[1] Med Univ S Carolina, Charleston, SC 29425 USA
关键词
D O I
10.1086/587647
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BACKGROUND. Colonization with vancomycin-resistant Enterococcus (VRE) is a risk factor for subsequent VRE bloodstream infection ( BSI); however, risk factors for BSI among colonized patients have not been adequately described. We sought to determine the proportion of VRE-colonized patients who subsequently develop VRE BSI and to identify risk factors for VRE BSI among these patients. METHODS. Records of 768 patients colonized with VRE from January 2002 through June 2005 were reviewed. The proportion of patients who developed VRE BSI was calculated, and the characteristics of these patients were compared, in a 2 : 1 ratio, with those of patients who did not develop VRE BSI. To identify risk factors for VRE BSI and for death, we used univariate logistic regression analysis and then multivariate logistic regression analysis. Using pulsed-field gel electrophoresis (PFGE), we compared the isolate recovered when the patient was colonized and the isolate recovered when the patient developed VRE BSI. RESULTS. Of the 768 patients colonized with VRE, 31 (4.0%) developed VRE BSI. Multivariate analysis identified the following idependent risk factors for developing VRE BSI: infection of an additional body site other than blood (adjusted odds ratio [aOR], 3.9; P = .04), admission to the hospital from a long-term care facility (aOR, 12.6; P = .04), and receipt of vancomycin (aOR, 10.6; P < .001). The independent risk factors for death among patients colonized with VRE were immunosuppression (aOR, 12.9; P = .001) and VRE BSI (aOR, 9.1 P =.002). Of the 31 patients who developed VRE BSI, 23 (74%) had a pair of isolates representing VRE colonization and VRE BSI. For 19 (83%) of these 23 patients, the isolate representing BSI was genetically related to the isolate representing VRE colonization: 12 pairs of isolates (52%) had identical banding patterns, 5 had closely related patterns, and 2 had possibly related patterns. CONCLUSION. Of the 768 patients colonized with VRE, 31 (4.0%) usually developed VRE BSI due to a related strain. Independent risk factors for BSI among colonized patients were admission from a long-term care facility, infection of an additional body site, and exposure to vancomycin. Independent risk factors for death were immunosuppression and VRE BSI.
引用
收藏
页码:404 / 409
页数:6
相关论文
共 34 条
[1]   Epidemiology and clinical consequences of vancomycin-resistant enterococci in liver transplant patients [J].
Bakir, M ;
Bova, JL ;
Newell, KA ;
Millis, JM ;
Buell, JF ;
Arnow, PM .
TRANSPLANTATION, 2001, 72 (06) :1032-1037
[2]   The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients [J].
Bhorade, SM ;
Christenson, J ;
Pohlman, AS ;
Arnow, PM ;
Hall, JB .
CHEST, 1999, 115 (04) :1085-1091
[3]   The role of "colonization pressure" in the spread of vancomycin-resistant enterococci - An important infection control variable [J].
Bonten, MJM ;
Slaughter, S ;
Ambergen, AW ;
Hayden, MK ;
van Voorhis, J ;
Nathan, C ;
Weinstein, RA .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (10) :1127-1132
[4]   Vancomycin-resistant Enterococcus faecium in a long-term care facility [J].
Brennen, C ;
Wagener, MM ;
Muder, RR .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (02) :157-160
[5]   Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients:: An analysis of two case-control studies [J].
Campos Furtado, Guilherme Henrique ;
Mendes, Rodrigo Elisandro ;
Campos Pignatari, Antonio Carlos ;
Wey, Sergio Barsanti ;
Servolo Medeiros, Eduardo Alexandrino .
AMERICAN JOURNAL OF INFECTION CONTROL, 2006, 34 (07) :447-451
[6]   National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004 [J].
Cardo, D ;
Horan, T ;
Andrus, M ;
Dembinski, M ;
Edwards, J ;
Peavy, G ;
Tolson, J ;
Wagner, D .
AMERICAN JOURNAL OF INFECTION CONTROL, 2004, 32 (08) :470-485
[7]   Health and economic outcomes of vancomycin-resistant enterococci [J].
Carmeli, Y ;
Eliopoulos, G ;
Mozaffari, E ;
Samore, M .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (19) :2223-2228
[8]   The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci -: A meta-analysis [J].
Carmeli, Y ;
Samore, MH ;
Huskins, WC .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (20) :2461-2468
[9]   Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: A meta-analysis [J].
DiazGranados, CA ;
Zimmer, SM ;
Klein, M ;
Jernigan, JA .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (03) :327-333
[10]   Vancomycin-resistant enterococcal bacteremia: Natural history and attributable mortality [J].
Edmond, MB ;
Ober, JF ;
Dawson, JD ;
Weinbaum, DL ;
Wenzel, RP .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (06) :1234-1239